191 related articles for article (PubMed ID: 37816198)
21. Quality of Life Analysis of a Radiation Dose-Escalation Study of Patients With Non-Small-Cell Lung Cancer: A Secondary Analysis of the Radiation Therapy Oncology Group 0617 Randomized Clinical Trial.
Movsas B; Hu C; Sloan J; Bradley J; Komaki R; Masters G; Kavadi V; Narayan S; Michalski J; Johnson DW; Koprowski C; Curran WJ; Garces YI; Gaur R; Wynn RB; Schallenkamp J; Gelblum DY; MacRae RM; Paulus R; Choy H
JAMA Oncol; 2016 Mar; 2(3):359-67. PubMed ID: 26606200
[TBL] [Abstract][Full Text] [Related]
22. PROTECT Trial: A cluster-randomized study with hydroxychloroquine versus observational support for prevention or early-phase treatment of Coronavirus disease (COVID-19): A structured summary of a study protocol for a randomized controlled trial.
Nanni O; Viale P; Vertogen B; Lilli C; Zingaretti C; Donati C; Masini C; Monti M; Serra P; Vespignani R; Grossi V; Biggeri A; Scarpi E; Galardi F; Bertoni L; Colamartini A; Falcini F; Altini M; Massa I; Gaggeri R; Martinelli G
Trials; 2020 Jul; 21(1):689. PubMed ID: 32736597
[TBL] [Abstract][Full Text] [Related]
23. Impact of Electronic Self-Assessment and Self-Care Technology on Adherence to Clinician Recommendations and Self-Management Activity for Cancer Treatment-Related Symptoms: Secondary Analysis of a Randomized Controlled Trial.
Knoerl R; Hong F; Blonquist T; Berry D
JMIR Cancer; 2019 Jan; 5(1):e11395. PubMed ID: 30622093
[TBL] [Abstract][Full Text] [Related]
24. Age-related differences in patient-reported outcomes in patients with advanced lung cancer receiving anti-PD-1/PD-L1 therapy.
King-Kallimanis BL; Kanapuru B; Blumenthal GM; Theoret MR; Kluetz PG
Semin Oncol; 2018 Aug; 45(4):201-209. PubMed ID: 30482633
[TBL] [Abstract][Full Text] [Related]
25. App-Controlled Treatment Monitoring and Support for Patients With Head and Neck Cancer Undergoing Radiotherapy: Results From a Prospective Randomized Controlled Trial.
Sprave T; Pfaffenlehner M; Stoian R; Christofi E; Rühle A; Zöller D; Fabian A; Fahrner H; Binder H; Schäfer H; Gkika E; Grosu AL; Heinemann F; Nicolay NH
J Med Internet Res; 2023 Oct; 25():e46189. PubMed ID: 37856185
[TBL] [Abstract][Full Text] [Related]
26. SYMptom monitoring with Patient-Reported Outcomes using a web application among patients with Lung cancer in the Netherlands (SYMPRO-Lung): study protocol for a stepped-wedge randomised controlled trial.
Billingy NE; Tromp VNMF; Veldhuijzen E; Belderbos J; Aaronson NK; Feldman E; Hoek R; Bogaard HJ; Onwuteaka-Philipsen BD; van de Poll-Franse L; Hugtenburg JG; van den Hurk CJG; Becker-Commissaris A; Walraven I
BMJ Open; 2021 Sep; 11(9):e052494. PubMed ID: 34518276
[TBL] [Abstract][Full Text] [Related]
27. Prophylactic antibiotics or G(M)-CSF for the prevention of infections and improvement of survival in cancer patients receiving myelotoxic chemotherapy.
Skoetz N; Bohlius J; Engert A; Monsef I; Blank O; Vehreschild JJ
Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD007107. PubMed ID: 26687844
[TBL] [Abstract][Full Text] [Related]
28. App-Controlled Treatment Monitoring and Support for Head and Neck Cancer Patients (APCOT): Protocol for a Prospective Randomized Controlled Trial.
Sprave T; Zöller D; Stoian R; Rühle A; Kalckreuth T; Haehl E; Fahrner H; Binder H; Grosu AL; Heinemann F; Nicolay NH
JMIR Res Protoc; 2020 Dec; 9(12):e21693. PubMed ID: 33295291
[TBL] [Abstract][Full Text] [Related]
29. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
30. A Mobile Health Intervention Supporting Heart Failure Patients and Their Informal Caregivers: A Randomized Comparative Effectiveness Trial.
Piette JD; Striplin D; Marinec N; Chen J; Trivedi RB; Aron DC; Fisher L; Aikens JE
J Med Internet Res; 2015 Jun; 17(6):e142. PubMed ID: 26063161
[TBL] [Abstract][Full Text] [Related]
31. The HOPE Pilot Study: Harnessing Patient-Reported Outcomes and Biometric Data to Enhance Cancer Care.
Wright AA; Raman N; Staples P; Schonholz S; Cronin A; Carlson K; Keating NL; Onnela JP
JCO Clin Cancer Inform; 2018 Dec; 2():1-12. PubMed ID: 30652585
[TBL] [Abstract][Full Text] [Related]
32. A short, animated video to improve good COVID-19 hygiene practices: a structured summary of a study protocol for a randomized controlled trial.
Vandormael A; Adam M; Greuel M; Bärnighausen T
Trials; 2020 Jun; 21(1):469. PubMed ID: 32493460
[TBL] [Abstract][Full Text] [Related]
33. ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial.
McEniery CM; Fisk M; Miles K; Kaloyirou F; Hubsch A; Smith J; Wilkinson IB; Cheriyan J
Trials; 2020 Jul; 21(1):604. PubMed ID: 32616067
[TBL] [Abstract][Full Text] [Related]
34. A multisite randomized controlled trial of an early palliative care intervention in children with advanced cancer: The PediQUEST Response Study Protocol.
Dussel V; Orellana L; Holder R; Porth R; Avery M; Wolfe J
PLoS One; 2022; 17(11):e0277212. PubMed ID: 36346783
[TBL] [Abstract][Full Text] [Related]
35. Pilot randomized trial of an electronic symptom monitoring intervention for hospitalized patients with cancer.
Nipp RD; El-Jawahri A; Ruddy M; Fuh C; Temel B; D'Arpino SM; Cashavelly BJ; Jackson VA; Ryan DP; Hochberg EP; Greer JA; Temel JS
Ann Oncol; 2019 Feb; 30(2):274-280. PubMed ID: 30395144
[TBL] [Abstract][Full Text] [Related]
36. Using IT to Improve Outcomes for Children Living With Cancer (SyMon-SAYS): Protocol for a Single-Institution Waitlist Randomized Controlled Trial.
Lai JS; Jensen SE; Peipert JD; Mitchell SA; Garcia SF; Cella D; Goldman S; Lenzen A
JMIR Res Protoc; 2023 Sep; 12():e50993. PubMed ID: 37682593
[TBL] [Abstract][Full Text] [Related]
37. Patient-reported tolerability of veliparib combined with cisplatin and etoposide for treatment of extensive stage small cell lung cancer: Neurotoxicity and adherence data from the ECOG ACRIN cancer research group E2511 phase II randomized trial.
Steffen McLouth LE; Zhao F; Owonikoko TK; Feliciano JL; Mohindra NA; Dahlberg SE; Wade JL; Srkalovic G; Lash BW; Leach JW; Leal TA; Aggarwal C; Cella D; Ramalingam SS; Wagner LI
Cancer Med; 2020 Oct; 9(20):7511-7523. PubMed ID: 32860331
[TBL] [Abstract][Full Text] [Related]
38. Implementation of Electronic Patient-Reported Outcomes for Symptom Monitoring in a Large Multisite Community Oncology Practice: Dancing the Texas Two-Step Through a Pandemic.
Patt D; Wilfong L; Hudson KE; Patel A; Books H; Pearson B; Boren R; Patil S; Olson-Celli K; Basch E
JCO Clin Cancer Inform; 2021 May; 5():615-621. PubMed ID: 34085537
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
